Patents
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
08/2001
08/30/2001WO2001062744A2 Substituted piperazine compounds
08/30/2001WO2001062742A1 Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
08/30/2001WO2001062704A1 Novel use of phenylheteroalkylamine derivatives
08/30/2001US20010018439 Antidiabetic agents
08/30/2001CA2657986A1 Substituted piperazine compounds
08/30/2001CA2397234A1 Novel use of phenylheteroalkylamine derivatives
08/29/2001EP1127869A1 Novel compounds and medicinal use thereof
08/29/2001EP1126838A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
08/29/2001CN1310702A Nitric ester and nitrate salts of specific drugs
08/29/2001CN1310621A Substituted anilide compounds and methods
08/29/2001CN1309898A Pesticide containing 0-benzyl oximeether derivative and its use
08/29/2001CN1070173C Benzoylaguanidine derivatives using as medicine
08/28/2001US6281363 Antiinflammatory agents; antiarthritic agents; autoimmune disorders
08/28/2001US6280859 Light-emitting material for organo-electroluminescence device and for organic electroluminescence device which the material is applied
08/23/2001WO2001060806A2 Substituted arylpyrazines
08/23/2001WO2001060803A1 Fused imidazolium derivatives
08/23/2001WO2001007436A3 Substituted oxoazaheterocyclyl compounds
08/23/2001CA2651825A1 Substituted arylpyrazines
08/23/2001CA2398937A1 Substituted arylpyrazines
08/22/2001EP1125930A1 Optically active piperazine-2-carboxylic acid derivatives and process for their preparation
08/22/2001EP0799210B1 Piperazine-2,5-dione derivatives as modulators of multidrug resistance
08/22/2001CN1309649A Polyhydroalkylpyrazine derivs. and their preparation and medicines contg. them
08/22/2001CN1309648A Piperazinone derivs. and their uses
08/22/2001CN1309116A Cyclic amine substd. phenylalkanone and preparing method thereof
08/21/2001US6278017 Continuous process for the preparation of N-(phosphonomethyl)iminodiacetic acid
08/16/2001WO2001058852A2 (r)-2-aryl-propionamides, useful in the inhibition of il-8-induced chemiotaxis of neutrophils
08/16/2001WO2001010842A3 Melanocortin-4 receptor binding compounds and methods of use thereof
08/16/2001WO2000076974A3 Oligomers and polymers of cyclic imino carboxylic acids
08/16/2001WO2000039104A9 Phenazine compounds, methods and pharmaceutical compositions for inhibiting parp
08/16/2001WO2000012609A8 Flame retardant polymer blends, and method for making
08/16/2001US20010014646 Bidentate ligands bonded to nickel, palladium, cobalt, or iron, and optionally, one or more neutral Lewis acids
08/16/2001US20010014462 Coupling an enzyme-substrate reaction with a tetrazolium salt and the transfer of free electrons from the reaction to the tetrazolium salt to produce a fluorescent formazan while assaying for enzyme activity; nonradioactive detection
08/15/2001CN1308616A Non-peptidyl inhibitors and VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory disease
08/15/2001CN1308251A Photographic element, compound and method containing azacyclo-substrated color former
08/14/2001US6274806 Dye sensitized electrode of a substrate with electrical conductive surface, an oxide semiconductor film formed on it, which supports a platinum complex
08/14/2001US6274600 Heteroatom substituted benzoyl derivatives that enhance synaptic responses mediated by AMPA receptors
08/14/2001US6274584 Peptide derivatives; bioavailability; enzyme resistance; milk and wool production
08/14/2001US6274336 Producing three-dimensional structure of active site using computer program, displaying and superimposing three-dimensional representation of test compound onto active site, preparing test compound, and testing in biological assay
08/09/2001WO2001057023A1 Heterocyclic amide derivatives
08/09/2001WO2001057021A2 2-[1H]-QUINOLONE AND 2-[1H]-QUINOXALONE INHIBITORS OF FACTOR Xa
08/09/2001WO2001056358A2 Enhanced propertied pesticides
08/09/2001WO2001010834A9 Antibacterial agents
08/09/2001WO2000071506A3 Naphthalene ureas as glucose uptake enhancers
08/09/2001US20010012894 Process for preparing alkoxypyrazine derivatives
08/09/2001US20010012848 An indane-like compounds which can be useful for treating psychosis and other conditions associated with modulation of a muscarinic receptor
08/09/2001CA2399214A1 Novel heterocyclic amide derivatives
08/08/2001EP1122242A1 Cyanophenyl derivatives
08/08/2001EP1121342A1 Diaminopropionic acid derivatives
08/08/2001EP1121128A1 A method of modulating ion channel functional activity
08/07/2001US6271374 Stable crystalline (6S)- and (6R)-tetrahydrofolic acid
08/07/2001US6271238 Useful in treating and preventing diseases involving chymotrypsin type proteases which are related to asthma, allergy, inflammations, rheumatism, hypertension, heart failure, myocardial infarction, and cardiac hypertrophy
08/07/2001US6271232 Collagenase-1 and stromelysin-1 inhibitors, pharmaceutical compositions comprising same and methods of their use
08/02/2001WO2001055115A1 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof
08/02/2001WO2001055110A1 Isatine derivatives with neurotrophic activity
08/02/2001WO2001055082A2 Intermediates for biologically active compounds
08/02/2001WO2001054691A1 Nitrate salts of antimicrobial agents
08/02/2001WO2001054481A2 Enhanced propertied pharmaceuticals
08/02/2001WO2000076971A3 Serine protease inhibitors
08/02/2001WO2000067847A3 Use of dopamine d3 receptor ligands for producing medicaments for treating kidney disorders
08/02/2001WO2000066564A8 Benzimidazolones and analogues and their use as progesterone receptor ligands
08/02/2001CA2397831A1 Enhanced propertied pharmaceuticals
08/02/2001CA2397754A1 Nitrate salts of antimicrobial agents
08/02/2001CA2397493A1 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof
08/02/2001CA2394292A1 Isatine derivatives with neurotrophic activity
07/2001
07/31/2001US6268366 Amide derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
07/31/2001US6268163 Identification of drug candidates modulating factor VII-mediated intracellular signaling
07/26/2001WO2001053274A1 Amide compounds for inhibiting protein kinases
07/26/2001WO2001053258A1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
07/26/2001WO2001004097A3 Cyclic delocalized cations connected by spacer groups
07/26/2001CA2398409A1 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound
07/26/2001CA2394703A1 Amide compounds for inhibiting protein kinases
07/25/2001EP1118907A2 Photographic element containing nitrogen heterocycle substituted cyan coupler, compound and process
07/25/2001EP1117397A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
07/25/2001CN1305477A Azablicyclic 5-HT, receptor ligands
07/25/2001CN1304930A Arylsulfurylisooximino acid derivative
07/24/2001US6265605 Additive in processed meat, beverages, and in other processed food stuffs; as intermediates in drugs, agricultural chemicals and pesticides, herbicides
07/24/2001CA2240594C 2,7-substituted octahydro-pyrrolo¬1,2-a|pyrazine derivatives
07/24/2001CA2218503C Arylsulfonyl hydroxamic acid derivatives
07/19/2001WO2001002345A3 Mono and multifunctional alkoxyamines for the preparation of functionalized macromers
07/19/2001WO2000076984A8 Novel compounds, their use and preparation
07/19/2001WO2000076970A3 Serine protease inhibitors
07/18/2001EP1116486A1 Medical composition containing nitroetheneamine derivative or salt thereof as active constituent
07/18/2001EP1115758A2 Polymerization of olefins
07/18/2001EP1115710A1 Process for preparing regiospecific substituted pyrazine isomers
07/18/2001EP1115707A1 Benzamide derivatives and ther use as cytokine inhibitors
07/18/2001CN1304404A Cyanoiminoquinoxaline derivatives
07/17/2001US6262060 Treatment of hyperglycaemia, diabetes, obesity or inflammation
07/12/2001WO2001027096A9 Aminomethyl-(hetero)aryl derivatives and their use as tryptase inhibitors
07/11/2001EP1114522A1 Rf receiver having cascaded filters and an intermediate amplifier stage
07/11/2001EP0948492B1 Process for the preparation of heteroaryl-phenylalanines
07/11/2001CN1303384A Pyrrolo [1,2-a] pyrazine sPLA2 inhibitor
07/11/2001CN1303376A Compound with activity on muscarinic receptors
07/11/2001CN1303281A Use of compounds for elevation of pyruvate dehydrogenase activity
07/11/2001CN1068327C 2,7-Substituted octahydro-1H-pyrido [1,2-alpha]pyrazin derivatives
07/11/2001CN1068308C Substituted benzoylguanide, its preparing process and medicine and application of same
07/10/2001US6258959 Process for the preparation of 2,4-dimethyl-3,5-bisalkoxycarbonylpyrrole
07/10/2001US6258822 Urokinase inhibitors
07/10/2001US6258813 D4 receptor selectivity piperazine derivatives
07/05/2001WO2001047899A1 Substituted piperazine derivatives as mtp inhibitors
07/05/2001WO2001047898A2 Substituted piperazine derivatives and their use as inhibitors of the microsomal triglyceride transfer protein (mtp)